Position in UTHR
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,382,208
+$1,296,578 QoQ
Shares Held
2,551
+756.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#413
of 870 holders
Holding Since
Sep 2024
4 quarters on record
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026iA Global Asset Management Inc. holds $25,098,205 across 5 Drug Manufacturers - Specialty & Generic names. UTHR ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
341,622 | $11,574,153 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
303,786 | $5,455,996 | |
| 3 | TRLV |
Trulieve Cannabis Corp.
|
522,992 | $5,141,011 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
9,166 | $1,544,837 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
2,551 | $1,382,208 |
All Filings in UTHR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,382,208 | 2,551 | Shares | Sole | 2026-07-29 | |
| 2025-06-30 | $85,630 | 298 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $199,450 | 647 | Shares | Sole | 2025-05-09 | |
| 2024-09-30 | $351,541 | 981 | Shares | Sole | 2024-11-15 | |
| No filing history on record for this holder in this stock. | ||||||